What are synthetic drugs?
New, synthetic versions of harmful drugs, including synthetic opioids and synthetic cannabinoids, are increasingly found in UK’s illegal drug markets.
Rare Cancers Bill 2024-2025
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
Controlled Drugs (Procedure for Specification) Bill
The Controlled Drugs (Procedure for Specification) Bill 2024-2025 had its second reading on Friday 7 March 2025. It was considered by a Public Bill Committee on 25 June 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
-
Insight
How are medicines prices set in the UK?
The price of medicines in the UK is influenced by multiple factors, including agreements with the pharmaceutical industry to cap spending on branded medicines.
-
Research Briefing
Antimicrobial resistance
Antimicrobial resistance (AMR) is a significant threat to public health. This briefing provides information on the causes and implications of the development and spread of AMR and about UK and international action to address it.
-
Debate Pack
Debate on long-term conditions
A Westminster Hall debate has been scheduled for 3pm on 12 June on long-term conditions. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Peter Prinsley MP.
-
Research Briefing
Infected Blood Inquiry: recommendations for recognition, healthcare and patient safety
The Infected Blood Inquiry made recommendations to improve patient care and safety, and strengthen the voice of patients in the healthcare system.
-
Research Briefing
Product Regulation and Metrology Bill [HL]: progress of the bill
The Product Regulation and Metrology Bill [HL] is scheduled to have its report stage in the House of Commons on 4 June 2025.
-
Debate Pack
Debate on research and treatment of brain tumours
A debate has been scheduled in the Commons Chamber for 8 May on research and treatment of brain tumours. The subject for this debate has been chosen by the Backbench Business Committee.
-
Debate Pack
Debate on an e-petition relating to the use of dogs in scientific and regulatory procedures
A debate has been scheduled in Westminster Hall for 28 April on an e-petition relating to the use of dogs in scientific and regulatory procedures.
-
Research Briefing
Medicines shortages
Find out about the causes and consequences of medicines shortages, and UK Government actions in response to supply disruption affecting human medicines.
-
Research Briefing
Product Regulation and Metrology Bill [HL] 2024-25
MPs will debate the Product Regulation and Metrology Bill [HL] at second reading on Tuesday 1 April 2025. The bill contains measures concerning the UK’s product safety, regulation and metrology framework.
-
Debate Pack
Debate on the first anniversary of the Hughes report on valproate and pelvic mesh
A Westminster Hall debate has been scheduled for 3pm on 27 March on the first anniversary of the Hughes report on valproate and pelvic mesh. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Sharon Hodgson MP.
-
Debate Pack
Debate on prevention of drugs deaths
A debate has been scheduled in Westminster Hall at 1.30pm on 27 March on prevention of drugs deaths. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.
-
Research Briefing
Medical use of cannabis
Cannabis is a controlled drug in the UK. Cannabis-based medicines can be prescribed by specialist doctors, but few such medicines have product licences.
Total results (page 1 of 2)